Pfizer Ltd. — Regulatory Filings 2024

May 6, 2024

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 6, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Board Meeting for consideration and to take on record the Audited Financial Results

for the Financial Year ended March 31, 2024.

• Ref.: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 17, 2024 , inter alia , to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2024 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2024.

Pursuant to the “Pfizer Limited – Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders”, the Trading Window of the Company was closed from March 31, 2024, till 48 hours after the results are made public on May 17, 2024.

Please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.05.06 19:15:40 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

• Cc: National Securities Depository Limited (NSDL) Central Depository Services (India) Limited (CDSL)

• KFin Technologies Limited

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in